Skip to content

Research for key technology and applications for catheter ablation of ventricular arrhythmias guided by noninvasive three-dimensional electrocardiographic mapping

Research for key technology and applications for catheter ablation of ventricular arrhythmias guided by noninvasive three-dimensional electrocardiographic mapping

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002554
Enrollment
Unknown
Registered
2019-08-31
Start date
2019-09-03
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventricular arrhythmias

Interventions

Sponsors

First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with premature ventricular contractions (PVCs) and ventricular tachycardia (VT); 2. Patients aged between 18 and 80 years; 3. Patients with obvious symptoms of PVCs/VT but cannot be relieved or tolerate antiarrhythmic medicine; 4. Impaired left ventricular function or tachycardia-induced cardiomyopathy due to asymptomatic PVCs/VT; 5. Frequent monomorphic PVCs/VT (>10000 per 24 h or burden >10%); 6. Informed consent can be obtained.

Exclusion criteria

Exclusion criteria: 1. Failure or abandonment of the ablation procedure; 2. Sustained ventricular tachycardia, Torsade de pointes, ventricular flutter or ventricular fibrillation; 3. PVCs/VT due to reversible reasons (electrolyte disturbance, acute ischemia, hyperthyroidism, etc); 4. Infrequent monomorphic PVCs(=level III; 8. Other severe cardiac dysfunction, cardiac ion channel diseases, inherited arrhythmogenic diseases and so on; 9. complicated with other severe diseases (e.g. hepatic and renal dysfunction, malignant tumor); 10. pregnancy or be allergic to iodic contrast medium.

Design outcomes

Primary

MeasureTime frame
acute successful rate;whole fluoroscopic exposure;total procedure time;

Secondary

MeasureTime frame
long-term success rate;mapping accuracy;

Countries

China

Contacts

Public ContactXinbin Zhou

First Affiliated Hospital of Zhejiang Chinese Medical University

zhouxinbin@zcmu.edu.cn+86 15158190118

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026